Vitamin K2‑Dependent Activation of Matrix Gla Protein May Slow Vascular Calcification

Emerging evidence links vitamin K2 supplementation to reduced arterial calcification

In a 2025 dialysis cohort, daily vitamin K2 (menaquinone‑7) halted progression of abdominal aortic calcification compared with placebo, suggesting a protective cardiovascular effect Inhibiting progression of abdominal aortic calcification by vitamin K2 in dialysis patients (2025). This finding revives interest in the vitamin’s role as a cofactor for matrix Gla protein (MGP), a potent inhibitor of ectopic mineral deposition.

Comparison of abdominal aortic calcification change over 12 weeks in dialysis patients receiving vitamin K2 versus placebo, based on two studies.
Sources: https://www.semanticscholar.org/paper/57f78de7c4099bf977480409713a7d98456bf721 · https://doi.org/10.1136/openhrt-2021-001715

Why vitamin K2 matters for MGP

MGP is a small extracellular protein that must undergo γ‑carboxylation of its glutamate residues to bind calcium ions effectively. The enzyme γ‑glutamyl carboxylase uses reduced vitamin K (K2) as a cofactor; without sufficient K2, MGP remains under‑carboxylated (ucMGP) and loses its inhibitory capacity Vitamin K(2)-a neglected player in cardiovascular health (2021). Fully carboxylated MGP (cMGP) anchors to the vascular wall, where it sequesters calcium‑phosphate crystals and blocks osteogenic signaling pathways that drive smooth‑muscle cells toward a bone‑like phenotype.

Connecting the research thread

Observational work has consistently linked low vitamin K status to greater vascular calcification Vitamin K status and vascular calcification (2012). A narrative review further highlighted that vitamin K2 supplementation improves cMGP levels and correlates with slower coronary artery calcium accrual Vitamin K(2)-a neglected player in cardiovascular health (2021). Together, these studies suggest a mechanistic chain: K2 → MGP carboxylation → reduced calcium deposition.

Self‑experiment protocol (14‑day n‑of‑1)

Readers can test this pathway on themselves using a simple, low‑risk protocol.

• Intervention: 180 µg of MK‑7 (vitamin K2) taken once daily with a fat‑containing meal.
• Control window: First 7 days – no supplement (baseline).
• Measurement plan: Record resting heart‑rate variability (RMSSD) each morning using a chest‑strap HR monitor; capture pulse wave velocity (PWV) at day 0, day 7, and day 14 with a fingertip tonometer.
• Null hypothesis: Vitamin K2 does not change RMSSD or PWV relative to the baseline period.

Because MGP carboxylation changes are not easily measurable at home, we use HRV and PWV as indirect proxies: improved vascular compliance often coincides with higher parasympathetic tone, which can manifest as modest RMSSD elevations Vitamin K Status and Vascular Calcification : Evidence from Observational and Clinical Studies (2012). A consistent upward trend in RMSSD across the supplementation window, coupled with a reduction in PWV, would support the hypothesis that K2‑driven MGP activation is enhancing arterial health.

Caveats and open questions

The evidence base remains limited to relatively small cohorts and short‑term outcomes. We do not yet know the dose‑response curve for MK‑7 in healthy adults, nor the time required for measurable changes in cMGP levels. Long‑term trials are needed to confirm whether the modest improvements in HRV or PWV translate into clinically meaningful reductions in coronary artery disease events. Additionally, interactions with other fat‑soluble vitamins (D, A) may modulate the effect, a factor not addressed in the current literature.

References

1. H. Menjo, Tanaka Tomoki, Ryousuke Umeda (2025). #1671 Inhibiting progression of abdominal aortic calcification by vitamin K2 in dialysis patients. Nephrology, Dialysis and Transplantation. https://doi.org/10.1093/ndt/gfaf116.1565
2. M. Shea, Rachel M. Holden (2012). Vitamin K status and vascular calcification: evidence from observational and clinical studies.. Advances in Nutrition. https://doi.org/10.3945/an.111.001644
3. Sharifa AlBlooshi (2025). Vitamin K and women's health: a review. Frontiers in Global Women's Health. https://doi.org/10.3389/fgwh.2025.1590414
4. M. Mulekar (2025). Microencapsulation-Based Functional Foods: Synergistic Delivery of Bovine Colostrum and Vitamin K? for Bone and Immune Health. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2025.75235
5. M. Shea, Rachel M. Holden (2012). Vitamin K Status and Vascular Calcification : Evidence from Observational and Clinical Studies 1 , 2. https://www.semanticscholar.org/paper/ecc8d3227d3b25f5e4461140978dae8f4b2a57f3
6. Hariri E, Kassis N, Iskandar JP (2021). Vitamin K(2)-a neglected player in cardiovascular health: a narrative review.. Open heart. https://doi.org/10.1136/openhrt-2021-001715